Axiom Intelligence I

These definitive terms materially reduce execution risk by contractually forbidding Sponsor redemptions and front-loading a $15,000,000 diligence termination fee, which discourages opportunistic SPAC withdrawals during due diligence. The structured earnout and $12.00 sponsor liquidity trigger create measurable performance milestones that align long-term shareholder returns with post-merger trading volume. The explicit $3,500,000,000 valuation denominator anchors expectations for public float dilution, while the mandatory $30,000,000 PIPE threshold ensures adequate post-closing operating capital, directly impacting the sustainability of the combined entity's quantum computing and AI-driven optimization strategy.

The $206,030,469 trust balance anchors the maximum redemption exposure available to public shareholders prior to closing, directly impacting net proceeds available to fund operations post-deal. The Sponsor’s explicit surrender of Article 17.4 anti-dilution conversion ratios eliminates potential future dilution pathways outside the approved transaction structure. The layered earnout mechanism ties substantial management and shareholder compensation exclusively to sustained market performance thresholds ($12.50, $15.00, $17.50), signaling confidence in the target’s quantum computing and AI-driven optimization roadmap while transferring near-term execution risk to founders rather than public capital. The CEO’s personal $15,000,000 liability for unilateral diligence termination creates asymmetric contractual risk that discourages frivolous deal abandonment. Additionally, the target’s operational focus relies heavily on intellectual property assets, generative AI compliance frameworks, and proprietary software, with the Company representing that no material litigation, sanctions violations, or anticorruption breaches exist, though risks around market adoption, technological feasibility, and regulatory clearances remain material uncertainties per the Company’s forward-looking disclosures.

For redemption and trust tracking, the document does not amend the 2027-06-20 deadline or alter the stated per-share trust value, but it explicitly ties the $190 million trust-derived liquidity assumption to a zero-redemption scenario. The high private-holder rollover percentage signals substantial dilution for remaining public shares absent redemptions or external financing. This 8-K initiates the proxy/prospectus filing cycle, which will lock formal voting records, tender windows, and precise trust payout mechanics. Regarding business fundamentals, the attached press release attributes claims that Terra Quantum currently serves enterprise customers across financial services, manufacturing, pharmaceuticals, logistics, energy, government, and defense sectors. The company describes its technology stack as integrating proprietary quantum algorithms, quantum security solutions, hybrid quantum-classical computing, and AI-driven optimization into unified software platforms. While the filing characterizes the global quantum computing market as having a massive opportunity projected to grow substantially over coming decades, it provides no specific revenue figures or dollar-valued market size. Legal advisors are identified as Ellenoff Grossman & Schole LLP and Bratschi for Axiom, and Heussen Rechtsanwaltsgesellschaft mbH, Kellerhals Carrard, Winston & Strawn LLP, and Niedermann Rechtsanwälte for Terra Quantum. No active litigation is disclosed, though standard forward-looking statements caution about potential post-announcement legal proceedings and regulatory delays.

The announcement materially alters the redemption calculus and capital structure assumptions for Axiom shareholders. Because the $190 million trust-derived liquidity baseline and the 92% versus 8% ownership split are explicitly conditioned on Axiom public stockholders making no redemptions, investors tracking liquidation timelines and trust distributions must model redemption-heavy scenarios against these disclosed figures. The press release attributes Terra Quantum’s technology roadmap to founder and CEO Markus Pflitsch, who states the company offers a unified stack combining quantum computing, quantum-inspired optimization, artificial intelligence, and quantum cybersecurity designed for enterprise deployment rather than pure hardware development. Pflitsch and CTO Dr. Florian Neukart attribute commercial traction to the firm, noting ongoing revenue generation across financial services, manufacturing, pharmaceuticals, logistics, energy, government, and defense sectors. Terra Quantum management characterizes the addressable market as projecting substantial growth over the coming decades as enterprises adopt quantum solutions for optimization, simulation, machine learning, and cybersecurity applications. Axiom CEO Doug Ward attributes his endorsement to Terra Quantum’s combination of scientific excellence, proprietary technology, enterprise adoption, and deep-tech scaling track record. Dr. Eike Marx is named as the continuing CFO and Chief Strategic Officer. The press release confirms the combined entity will trade on Nasdaq under the ticker symbol “TQ.” Until the Form F-4 proxy statement/prospectus is filed, exact redemption mechanics, potential PIPE sizing, and final trust distribution per share remain unconfirmed, but this filing establishes the definitive valuation anchor, pro forma ownership matrix, and near-term closing target driving investor decisioning ahead of the June 2027 deadline.

The $10.30 per-share trust valuation directly dictates the maximum cash payout available to redeeming shareholders and influences redemption calculus as the hard June 20, 2027 deadline approaches. Management’s explicit confirmation of an unresolved acquisition hunt narrows the operational runway and explains the documented going concern warning triggered by the projected depletion of the $545,146 cash reserve against the unreduced $274,966 quarterly burn rate masked by temporary interest offsets. The recorded sponsor fee accruals and equity grants illustrate the financial incentives and voting alignments that will govern sponsor behavior during the final push for a European infrastructure target, while Management’s denial of pending litigation and affirmation of control effectiveness removes immediate legal or governance roadblocks from the remaining acquisition timeline.

For investors tracking SPAC timelines and capital, this report verifies the exact per-share trust valuation ahead of potential market fluctuations or extension votes, while confirming the extended timeline through mid-2027 provides ample runway to secure a European infrastructure target. The disclosure of limited cash reserves outside the trust (~$736,280) alongside administrative service agreements ($10,000/month to the Sponsor) highlights the operational funding constraints management must navigate before closing a deal. Furthermore, the adoption of executive compensation clawback and insider trading compliance policies establishes the corporate governance framework expected during the search phase.

The exact Trust balance of $200,181,454 directly dictates the maximum potential redemption price for Public Shareholders, while the June 17, 2028 Nasdaq deadline establishes the absolute outer boundary for extension mechanisms before mandatory delisting. The explicit lack of a selected acquisition target combined with $12,624,206 in sunk transaction costs underscores that sponsor-funded operational runway—supported by the $10,000/month administrative fees and potential loan conversions—is essential to preserve shareholder value ahead of target identification. The documented settlement of $956,101 in pre-IPO financing obligations by the Sponsor reduces near-term liquidity risk and signals continued financial backing, mitigating short-term liquidation exposure for Public Shareholders.

The explicit absence of target engagements confirms the SPAC remains in a pure capital-search phase, tethering public value strictly to the documented trust floor plus accrued interest net of taxes. The sponsor liability provision, insider waiver structures, and rigid 24-month liquidation timeline collectively establish a defined downside ceiling and mandatory exit path for investors. Structural safeguards—such as restricting trust investments to short-term Treasuries or cash to prevent Investment Company Act classification, and clarifying that creditor claims are documented to potentially priority over public shareholder claims—dictate liquidity risk assessment. Furthermore, the forfeiture of 41,666 founder shares following the partial over-allotment exercise and the valuation of director grants at $1.575 per share demonstrate precise equity dilution mechanics and compensation alignment metrics that govern ongoing sponsor conduct and public shareholder protection until a transaction materializes.

This filing mechanically locks the redemption timeline and liquidation parameters. It fixes the per-share trust starting value at $10.00, triggers mandatory pro-rata redemption if the June 20, 2027 deadline passes, and permits up to $100,000 of trust interest to cover dissolution expenses. The notes confirm that the sponsor, officers, and directors waive redemption rights on their founder and private placement shares, pledge to vote those shares in favor of the business combination, and accept liability to restore the trust to $10.00 per share if third-party claims reduce it below that floor. The 80% fair market value acquisition test is explicitly tied to the net trust balance excluding deferred underwriting discounts and taxes. Regarding operations and strategy, the company identifies its target sector as European infrastructure but discloses it has selected no specific target and conducted no substantive discussions. Financial disclosures show total assets of $200,286,600, a working capital deficit of $843,803, and an accumulated deficit of $6,738,730, with the sponsor extending working capital advances and a promissory note to fund pre-combination activities.

Establishes the fully funded trust account ($200,000,000), which dictates the baseline cash available for redemption payouts or acquisition financing. Solidifies the standard 24-month completion window (approximately June 2027), setting a clear horizon for deal pursuit or liquidation. Clarifies sponsor alignment through mandatory favorable voting, share forfeiture provisions upon failed deadlines, and executive lock-ups, reducing near-term dilution and agency risk while defining the operational cost structure and governance framework ahead of target identification.

The document materially repositions the investment calculus by locking in severe dilution vectors, explicit timeline boundaries, and asymmetric sponsor incentives that prioritize management recovery over public shareholder returns. The 24-to-36-month redemption window anchors the exact capital-return horizon, while the $10.00 per-unit pricing and pro rata trust distribution formula replace any assumed $10.00 trust convention with precise, legally defined payout mechanics.

Investors tracking deal progress and capital preservation should note this filing serves purely as an executive registry update rather than a strategic disclosure. The report attributes no forward-looking claims, customer pipelines, revenue projections, technology roadmaps, or partnership developments to the company or its officers. Management conduct appears routine and compliant, with no signals of accelerated cash burn, altered sponsor forfeiture risk, or changed target diligence milestones. As a result, the filing does not trigger redemption pressure nor alter the trajectory toward the 2027-06-20 cutoff, though it satisfies statutory transparency requirements ahead of any eventual trust distribution or SPAC dissolution event.

Establishes the core terms of the SPAC IPO: $10.00 per unit trust, 24-month completion window, redemption rights at trust value, sponsor/underwriter private placement units, founder share conversion with anti-dilution, and detailed conflicts of interest. This is the foundational disclosure for evaluating the SPAC's structure, sponsor incentives, and investor protections prior to any business combination.

This is the foundational IPO filing for a newly formed SPAC, defining the trust value, redemption mechanics and business-combination deadline that will drive future AXIN tracking. The provided DEAL_ANNOUNCED status is not consistent with this document, which explicitly states no target has been selected or discussed. Investors should focus on effectiveness and closing of the IPO; from closing, the 24-month completion window, $10.00-per-unit trust deposit and $0.40-per-unit deferred underwriting commission will determine future redemption values and deal economics.

This is a brand new SPAC IPO filing seeking to raise $150M to target European infrastructure companies. Key numbers for redemption tracking: initial trust $10.00/share, 24-month deadline, 15% redemption limitation per shareholder. The sponsor's nominal cost ($0.004/share) creates significant dilution risk for public holders. The non-managing sponsor investors' expressed but non-binding interest introduces potential concentration risk but their exact commitment is not disclosed. President Daniel Mamadou serves as CEO of another SPAC (Welsbach Technology Metals Acquisition Corp) that has pending de-SPAC deadline of June 30, 2025 — a potential conflict of interest.

Although the filing leaves the 2027-06-20 deadline and trust/share value unchanged, it materially reshapes the information available for holder decisions by binding sponsor economic alignment, extension penalties, and conflict-allocation protocols into the S-1 record. The Company’s explicit acknowledgment that non-managing sponsor investors are structurally motivated to consummate a deal—even at prices that might trigger redemptions—gives investors a concrete metric for evaluating downside risk. Furthermore, the revisions to pages 44, 125, 127, and 157 regarding how target opportunities will be shared across concurrent SPACs, combined with the updated narrative on pages 7, 115, 126, and 157 about management having previously rejected targets in earlier vehicles, supply actionable intelligence on deal sourcing bandwidth and historical underwriting standards. Investors can now cross-reference the newly documented dilution vectors, extension cost structures, and sponsor override incentives against the remaining calendar before the final prospectus locks.

Management’s characterization of the European infrastructure sector as the exclusive search focus introduces concentration risk, as the filing projects a US$2 trillion regional investment gap by 2040, a $118.2 billion European data center market by 2032, a $92.5 billion power transmission and distribution sector by 2030, and a potential $200 to $280 billion value unlock from generative AI adoption in telecommunications. These market size assertions originate solely from external research reports cited by the registrant and represent unverified target criteria.

This comment letter places direct conditions on the S-1’s path to effectiveness, which gates final pricing, merger timeline, and redemption calendar finalization. By forcing explicit enumeration of extension caps and sponsor penalties upon extension failure, the SEC ensures the document clearly maps shareholder exit windows and potential trust distribution triggers tied to the June 20, 2027 deadline. The mandate to disclose cross-SPAC target allocation mechanisms establishes baseline accountability for sponsor conflict-of-interest governance as the team manages multiple vehicles concurrently.

The document codifies structural advantages and risks that directly impact redemption valuations and sponsor incentives. The prospectus explicitly notes that public shareholders will incur immediate and substantial dilution—projected at 98.1% under maximum redemption scenarios—due to the nominal founder share cost and anti-dilution conversion mechanics that could issue Class A shares on a greater-than-one-to-one ratio.

What changed: SEC Form 425 submitting an English-translated podcast interview featuring Terra Quantum AG Chief Executive Officer Markus Pflitsch, filed pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12 in connection with the pending business combination between Terra Quantum AG and Axiom Intelligence Acquisition Corp 1. This filing does not amend the SPAC redemption mechanics, the per-share trust value of $10.21, or the liquidation deadline of June 20, 2027. It reports no change to the sponsor relationship, redemption thresholds, or extension provisions. Deal progress remains directed toward a second half of 2026 Nasdaq listing, consistent with the May 29, 2026 Form 8-K announcement. The filing instead introduces newly published operational, strategic, and commercial disclosures from the target company’s leadership. Why it matters: Shareholders weighing redemption decisions against the $10.21 trust value and June 20, 2027 deadline receive substantive forward-looking content from CEO Markus Pflitsch alongside explicit transaction risks. Attributed claims include a target valuation of approximately US$3.5 billion, deployment of quantum computing, quantum AI, quantum cybersecurity, and a proprietary encrypted messaging platform named Whisper, and active commercial engagement with the U.S. government and U.S. Air Force. Pflitsch states that current U.S. directives require roughly 250,000 critical infrastructure operators to adopt quantum-resistant encryption within the next few years, while U.S. government agencies he cites estimate Q-Day (when quantum systems can break public-key cryptography) around 2030, with one study suggesting 2029, creating a three or four year preparation window. He founded Terra Quantum in 2018 after nearly twenty years in corporate finance and banking, is fifty-five years old, and sets a corporate policy declining offensive warfare contracts under a “Quantum for Good” framework. The filing simultaneously catalogs standard deal hazards: potential SEC objections to the Form F-4 registration statement, failure to obtain stockholder approval, inability to meet Nasdaq listing standards, execution risk on projected financial information, commercialization uncertainty, and intellectual property protection challenges. For redemption tracking, the unchanged timeline and trust amount keep the opt-out window active through June 20, 2027, but the heavy dependence on unproven quantum hardware scaling, government procurement pacing, and regulatory clearance underscores the speculative path to realizing the stated valuation before trust expiration.

What changed: Form 425 – Prospectuses and Communications filed pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, submitted to place a published, English-translated Forbes Switzerland media interview on the record. No amendments to redemption procedures, trust/share value, extension triggers, or the June 20, 2027 deadline are reported. Deal progress statements reiterate a proposed business combination valued at approximately US$3.5 billion (CHF 2.8 billion) with expected Nasdaq listing under ticker TQ if closing occurs during the second half of 2026. Capital proceeds are capped at up to US$190 million, explicitly scaled down by the volume of Axiom shareholder redemptions before closing. Sponsor conduct is not addressed. Substance from the filing includes: Terra Quantum founder and CEO Markus Pflitsch claims the company employs more than 200 people (over 70 percent research engineers, more than 35 percent holding doctoral degrees), has raised more than US$100 million historically, operates across seven global locations, and holds more than 100 patents; he further states the firm does not publicly disclose current revenue figures. Pflitsch attributes customer engagements to the U.S. Air Force, Volkswagen, HSBC, Evonik, and Siemens, and asserts the U.S. government was the first sovereign entity to award Terra Quantum a contract. Market sizing and industry data cited include: McKinsey projects the global quantum industry could generate between US$1.3 trillion and US$2.7 trillion in economic value by 2035, identifying chemicals, advanced materials, energy, financial services, logistics, and pharmaceuticals as highest-potential sectors; the QED-C State of Quantum 2026 Report estimates the current market at approximately US$1.9 billion (around US$1.4 billion from quantum computing and another US$470 million from quantum sensing), tracks nearly 70,000 active quantum patents expanding at an average rate of approximately 20 percent annually, records US$12.7 billion in governmental quantum funding announcements in 2025 (a 310 percent jump), and surveys indicate 11 percent of quantum computing firms reported annual revenues exceeding US$5 million a year earlier versus 19 percent in 2025, with more than half anticipating at least 11 percent revenue growth in 2026. Pflitsch additionally lists IBM, Google, Microsoft, Quantinuum, IonQ, D-Wave, and Rigetti as industry participants competing for capital and talent. Why it matters: The filing leaves the SPAC’s statutory framework untouched—trust remains at $10.21 per share, the redemption window operates as previously set, and the liquidation deadline stays at June 20, 2027—but it delivers actionable target-level disclosure ahead of the definitive proxy statement/prospectus. The conditional financing ceiling (up to US$190 million net of redemptions) creates a direct feedback loop: heavier redemption expectations compress the cash runway earmarked for R&D acceleration, global sales expansion, and strategic acquisitions, thereby increasing execution pressure on the commercialization milestones Pflitsch emphasizes. Attributed claims about headcount composition, patent density, geographic footprint, and named enterprise clients provide baseline verification points for investors weighing the stated US$3.5 billion valuation against independent benchmarks like the McKinsey and QED-C market projections. Because the capital raise scales inversely with shareholder exit behavior, tracking pre-close subscription vs. redemption trends is critical; this transcript supplies neither mechanical updates nor extension signals, making the upcoming proxy date and corresponding prospectus the next definitive inflection point for trust preservation and closing probability.

What changed: SEC Form 425 filing containing a published ntv television interview transcript and standard Rule 14a-12 prospectus communication boilerplate submitted in connection with the proposed business combination between Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG. The filing imposes no adjustments to the redemption deadline (2027-06-20), the per-share trust value ($10.21), extension provisions, or sponsor governance. It solely routes a pre-existing media interview into the SEC filing system alongside mandatory solicitation disclaimers and recitations of outstanding closing conditions tied to the existing Business Combination Agreement. Deal mechanics remain unchanged: consummation still requires stockholder approval, SEC clearance of the Form F-4 registration statement, verification that the combined entity meets Nasdaq listing standards, and confirmation that no termination events have occurred under the merger agreement. Why it matters: Though procedurally routine for the SPAC timeline, the attached transcript establishes the public investment thesis Terra Quantum executives intend to advance ahead of an expected Nasdaq debut in the second half of the year. In the transcript, Markus Pflitsch stated that quantum computing will become critical for operating systems and algorithmic control of coordinated robot fleets once conventional AI reaches analytical limits, and he characterized the convergence of AI and quantum technologies as an imminent innovation wave. He asserted that Europe has already lost the classical AI race—citing U.S. dominance in user interfaces and foundational algorithms—and pointed to a visible funding gap reflected in valuation levels and market multiples as the reason Terra Quantum selected a U.S. exchange over German venues. Company disclosures in the same filing warn that success depends on technological feasibility, customer adoption, intellectual property retention, commercialization of quantum security and AI-driven optimization solutions, and sustained reliance on scientific talent and third-party infrastructure. Sponsor leadership remains identified as Richard Dodd (Executive Chairman) and Doug Ward (Chief Executive Officer), with no changes to compensation, conduct, or fiduciary obligations noted.

What changed: A Rule 425 prospectus communication and forward-looking statements filing reproduced by Axiom Intelligence Acquisition Corp 1, containing a LinkedIn post excerpt and an ntv Nachrichten interview summary regarding the proposed business combination with Terra Quantum AG, alongside standard securities law disclaimers, risk factors, and solicitation participant disclosures. The filing updates no mechanics. It does not modify the redemption deadline, alter the trust account status or per-share value, propose an extension, renegotiate deal terms, or reflect any sponsor conduct changes. It is a static informational submission filed solely to satisfy post-announcement communication requirements under the Securities Act of 1933. Why it matters: The filing substantively circulates the target’s stated metrics and strategic rationale ahead of the definitive proxy statement/prospectus. A LinkedIn post attached to the communication cites a '$3.5 billion dollar valuation' for Terra Quantum AG. In a summarized conversation with ntv Nachrichten, Markus Pflitsch attributes the shift toward a Nasdaq listing to 'more capital,' 'higher valuations,' and 'greater openness to innovation.' The filing’s forward-looking statements section explicitly flags investor risks surrounding Terra Quantum’s ability to commercialize 'quantum computing, quantum security, and AI-driven optimization solutions' amid emerging market adoption and technological feasibility uncertainties. Management identification is limited to Richard Dodd (Executive Chairman) and Doug Ward (Chief Executive Officer). For redemption-track investors, the primary takeaway is that the target’s U.S.-centric capitalization narrative is being actively promoted while the regulatory review clock continues uninterrupted.

What changed: This filing is a Form 425 written communication containing a Form 8-K current report and an attached investor presentation dated June 9, 2026, filed to authorize use of preliminary marketing materials for the proposed business combination between Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG. No adjustments to redemption terms, trust account status, or expiration deadline are reported. The filing confirms the Business Combination Agreement executed on May 25, 2026, remains pending shareholder approval via a forthcoming proxy statement/prospectus. Forward-looking statements in the disclosure explicitly warn that if a significant number of Axiom’s ordinary shares are elected to be redeemed, it will reduce the capital available to the post-combination company following the Business Combination and highly concentrate remaining share ownership. Pro forma financial assumptions presented by management indicate a requirement to raise $100M from a combination of PIPE and SPAC cash in trust, with $85M assumed to flow to the balance sheet after $15M in illustrative transaction expenses. Why it matters: Management attributes a $1.3Tn 2035 value creation opportunity in quantum computing to the broader sector, citing BCG and McKinsey research, and delineates addressable markets including Financial Services at $70B-$135B, Medicine & Chemicals at $60B-$130B, Aerospace & Defense at $30B-$70B, Clean Energy at $10B-$30B, Next Gen Batteries at $20B-$40B, Ad Optimization at $50B-$100B, Network Optimization at $50B-$100B, and Automotive at up to $10B. The company claims its proprietary, software-first quantum platform delivers >15x faster optimization, >200x improvement in simulation efficiency, and ~30% faster machine learning, attributing those performance metrics to external studies by Perelshtein et al. (2022) and Aliev et al. (2023). Commercial traction is claimed with enterprise customers including Thales, Uniper, Honda, Volkswagen Group, the U.S. Air Force, and Melita. An illustrative transaction model projects a $3.5B valuation for Terra Quantum and ~$3.6B pro forma enterprise value, implying roughly 95.5% ownership for existing Terra Quantum shareholders and ~2.7% for SPAC/PIPE investors. Public comparable companies reportedly averaged a ~$10.7B enterprise value as of 6/4/2026 per FactSet data cited in the deck. Risk factors highlight early-stage technology commercialization uncertainty, rapid industry evolution, dependence on key scientific personnel (Markus Pflitsch, Dr. Eike Marx, Dr. Florian Neukart), channel partner reliance, and the explicit impact of share redemptions on post-deal capital availability and float concentration.

What changed: Form 8-K (Regulation FD Disclosure) filing that furnishes Exhibit 99.1, a confidential investor presentation promoted in connection with the proposed business combination between Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG. This submission advances the merger timeline by delivering promotional materials to the SEC ahead of the forthcoming proxy statement/prospectus and shareholder vote. It does not amend the existing redemption deadline of June 20, 2027, nor does it introduce new trust account mechanics or extensions relative to the stated $10.21 per-share trust value. Why it matters: The presentation supplies the preliminary financial architecture and commercial thesis driving the deal. According to management and the attached deck, Terra Quantum claims a $1.3 trillion 2035 value creation opportunity sourced from BCG and McKinsey reports, segmented into Addressable Markets citing Financial Services at $70B-$135B, Medicine/Chemicals at $60B-$130B, Aerospace Defense at $30B-$70B, and several other verticals ranging up to $100B. The Company attributes performance differentials to peer-reviewed studies (Perelshtein et al., Aliev et al.), claiming its QKD network operates >10,000x faster than comparators, optimization runs >15x faster/more accurately, and simulation efficiency improves up to >200x. Management lists enterprise deployments and pilots with Thales, Uniper, Honda, Volkswagen Group, the U.S. Air Force, and Melita. Structurally, the deck projects a $3.5 billion base valuation for Terra Quantum, implying ~$3.6 billion pro-forma enterprise value. It assumes a $100 million PIPE and trust cash raise, a $10.00 assumed public share price, and 366.7 million total shares outstanding. The proposed cap table shows Terra Quantum shareholders rolling over 100% of their equity for ~95.5% ownership, SPAC/PIPE investors taking 2.7%, and the sponsor retaining 1.8%. Critically, the filing's risk factors explicitly warn that substantial shareholder redemptions will drain capital available to the surviving entity and highly concentrate post-combination ownership, while also noting that some Axiom officers and directors may face conflicts of interest in approving the deal.

What changed: Form 8-K filed pursuant to Rule 425 under the Securities Act disclosing a Business Combination Agreement dated May 25, 2026, between Axiom Intelligence Acquisition Corp 1 ('SPAC') and Terra Quantum AG ('Company'), together with an attached Sponsor Support Agreement and a form Shareholder Voting, Support and Lock-Up Agreement. The filing establishes definitive terms for a proposed business combination targeting a company the parties describe as developing, commercializing, and scaling 'quantum computing, quantum security and AI-driven optimization solutions' (attributed to SPAC and the Company in the Forward-Looking Statements section). Mechanics updated include: a Trust Account balance of $206,030,469; a valuation construct defining 'Price per Share' as the quotient of $3,500,000,000 divided by fully diluted outstanding Swiss HoldCo Shares; a mandatory effort obligation to secure at least $30,000,000 in PIPE investments; and a 75,000,000-share earnout pool (50,000,000 Swiss HoldCo Earnout Shares and 25,000,000 Management Earnout Shares) issuable in three tranches triggered by a 30-day VWAP of $12.50, $15.00, and $17.50 over an eight-year period. The Sponsor (Axiom Intelligence Holdings 1, LLC) irrevocably waives anti-dilution adjustments, vows not to redeem, pledges to vote in favor, and accepts a 180-day lock-up subject to a $12.00 VWAP breakout. SPAC Chief Executive Officer Douglas Ward personally guarantees a $15,000,000 diligence termination fee payable to the Company if SPAC elects to walk away during the diligence window. Why it matters: The $206,030,469 trust balance anchors the maximum redemption exposure available to public shareholders prior to closing, directly impacting net proceeds available to fund operations post-deal. The Sponsor’s explicit surrender of Article 17.4 anti-dilution conversion ratios eliminates potential future dilution pathways outside the approved transaction structure. The layered earnout mechanism ties substantial management and shareholder compensation exclusively to sustained market performance thresholds ($12.50, $15.00, $17.50), signaling confidence in the target’s quantum computing and AI-driven optimization roadmap while transferring near-term execution risk to founders rather than public capital. The CEO’s personal $15,000,000 liability for unilateral diligence termination creates asymmetric contractual risk that discourages frivolous deal abandonment. Additionally, the target’s operational focus relies heavily on intellectual property assets, generative AI compliance frameworks, and proprietary software, with the Company representing that no material litigation, sanctions violations, or anticorruption breaches exist, though risks around market adoption, technological feasibility, and regulatory clearances remain material uncertainties per the Company’s forward-looking disclosures.

What changed: An 8-K Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 disclosing the entry into a Business Combination Agreement, a Sponsor Support Agreement, and a form of Shareholder Voting, Support and Lock-Up Agreement. As drafted in the attached agreements, the transaction mechanics stipulate that the Sponsor Support Agreement binds the Sponsor—which Schedule A confirms holds 400,000 SPAC Class A Ordinary Shares, 6,666,667 SPAC Class B Ordinary Shares, and 400,000 SPAC Rights—to vote in favor of the merger and waive its right to redeem any Subject Shares. Sponsor shares are locked up for 180 days or until the PubCo Ordinary Shares’ 30-day VWAP reaches $12.00 for 20 trading days within a 30-trading day period. Section 4.13 of the Business Combination Agreement represents the Trust Account contains at least $206,030,469. The agreement may be terminated one year after the initial Proxy/Registration Statement filing, and Section 11.3 triggers a $15,000,000 Diligence Termination Fee payable by Douglas Ward if SPAC exercises sole discretion to abandon the deal during the Diligence Review Period. Regarding substantive business operations, Section 3.14 details the Company’s intellectual property portfolio, stating ownership of Owned IP including Patents, Trademarks, copyrights, mask works, and Trade Secrets essential to conducting business in quantum computing, quantum security, and AI-driven optimization solutions. Section 9.5 mandates reasonable best efforts to secure at least $30,000,000 in committed PIPE investments, while Section 2.7 structures an earnout of up to 50,000,000 Swiss HoldCo Earnout Shares and 25,000,000 Management Earnout Shares conditional on 30-day VWAP thresholds of $12.50, $15.00, and $17.50 over eight years. The proposed Price per Share is defined as the quotient of $3,500,000,000 divided by fully diluted Swiss HoldCo Shares. Post-closing governance establishes a seven-member board (five designated by the Company, two by SPAC) and a PubCo Incentive Equity Plan with a 10% initial fully diluted reserve plus a 5% annual evergreen provision. Why it matters: These definitive terms materially reduce execution risk by contractually forbidding Sponsor redemptions and front-loading a $15,000,000 diligence termination fee, which discourages opportunistic SPAC withdrawals during due diligence. The structured earnout and $12.00 sponsor liquidity trigger create measurable performance milestones that align long-term shareholder returns with post-merger trading volume. The explicit $3,500,000,000 valuation denominator anchors expectations for public float dilution, while the mandatory $30,000,000 PIPE threshold ensures adequate post-closing operating capital, directly impacting the sustainability of the combined entity's quantum computing and AI-driven optimization strategy.

What changed: Form 8-K filing under Rule 425 submitting a Regulation FD disclosure and an attached press release announcing a definitive Business Combination Agreement. Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG announced the execution of a definitive Business Combination Agreement dated May 25, 2026, moving the transaction from prior negotiations to a binding merger pathway. According to the attached press release, the deal assigns Terra Quantum an equity value of approximately $3.5 billion, representing an increase from a previously announced non-binding letter of intent, and cites a pro forma enterprise value of approximately $3.6 billion assuming no redemptions by Axiom’s public stockholders. Ownership is projected to allocate approximately 92% to existing Terra Quantum shareholders—who would roll 100% of their equity into the combined entity—and approximately 8% to Axiom’s public stockholders and sponsor, again assuming zero redemptions. The filing states the trust account funds available at the time of the IPO are expected to deliver up to approximately $190 million of gross proceeds to the combined company, excluding transaction costs and predicated on no redemptions. The structural plan identifies a Swiss public limited company as PubCo and a Cayman Islands exempted company as Merger Sub, with a closing target in the second half of 2026 subject to customary conditions. This document does not amend the redemption deadline, extend the trust period, or disclose modifications to sponsor conduct; standard prerequisites including Axiom shareholder approval, SEC registration statement effectiveness, and Nasdaq listing approval remain outstanding. Why it matters: The announcement materially alters the redemption calculus and capital structure assumptions for Axiom shareholders. Because the $190 million trust-derived liquidity baseline and the 92% versus 8% ownership split are explicitly conditioned on Axiom public stockholders making no redemptions, investors tracking liquidation timelines and trust distributions must model redemption-heavy scenarios against these disclosed figures. The press release attributes Terra Quantum’s technology roadmap to founder and CEO Markus Pflitsch, who states the company offers a unified stack combining quantum computing, quantum-inspired optimization, artificial intelligence, and quantum cybersecurity designed for enterprise deployment rather than pure hardware development. Pflitsch and CTO Dr. Florian Neukart attribute commercial traction to the firm, noting ongoing revenue generation across financial services, manufacturing, pharmaceuticals, logistics, energy, government, and defense sectors. Terra Quantum management characterizes the addressable market as projecting substantial growth over the coming decades as enterprises adopt quantum solutions for optimization, simulation, machine learning, and cybersecurity applications. Axiom CEO Doug Ward attributes his endorsement to Terra Quantum’s combination of scientific excellence, proprietary technology, enterprise adoption, and deep-tech scaling track record. Dr. Eike Marx is named as the continuing CFO and Chief Strategic Officer. The press release confirms the combined entity will trade on Nasdaq under the ticker symbol “TQ.” Until the Form F-4 proxy statement/prospectus is filed, exact redemption mechanics, potential PIPE sizing, and final trust distribution per share remain unconfirmed, but this filing establishes the definitive valuation anchor, pro forma ownership matrix, and near-term closing target driving investor decisioning ahead of the June 2027 deadline.

What changed: Form 8-K filing (Item 7.01 Regulation FD Disclosure) accompanied by Exhibit 99.1, a press release officially announcing a definitive Business Combination Agreement between Axiom Intelligence Acquisition Corp 1 (AXIN) and Terra Quantum AG. This filing formalizes the merger announcement, establishing an equity valuation of approximately $3.5 billion for Terra Quantum and an implied pro forma enterprise value of approximately $3.6 billion, assuming no redemptions. Pro forma ownership assumes Terra Quantum shareholders roll 100% of their equity into the transaction, resulting in approximately 92% ownership of the combined company, while Axiom’s public stockholders and sponsor are expected to own approximately 8%. The press release notes the SPAC trust account could deliver up to approximately $190 million in gross proceeds assuming no redemptions, with potential PIPE financing. Closing targets the second half of 2026, contingent on Axiom shareholder approval, Form F-4 registration statement effectiveness, customary conditions, regulatory approvals, and Nasdaq listing. Combined company leadership will comprise Founder & CEO Markus Pflitsch, CFO and Chief Strategic Officer Dr. Eike Marx, and CTO Dr. Florian Neukart. The combined company's Nasdaq ticker symbol is expected to be “TQ”. Why it matters: For redemption and trust tracking, the document does not amend the 2027-06-20 deadline or alter the stated per-share trust value, but it explicitly ties the $190 million trust-derived liquidity assumption to a zero-redemption scenario. The high private-holder rollover percentage signals substantial dilution for remaining public shares absent redemptions or external financing. This 8-K initiates the proxy/prospectus filing cycle, which will lock formal voting records, tender windows, and precise trust payout mechanics. Regarding business fundamentals, the attached press release attributes claims that Terra Quantum currently serves enterprise customers across financial services, manufacturing, pharmaceuticals, logistics, energy, government, and defense sectors. The company describes its technology stack as integrating proprietary quantum algorithms, quantum security solutions, hybrid quantum-classical computing, and AI-driven optimization into unified software platforms. While the filing characterizes the global quantum computing market as having a massive opportunity projected to grow substantially over coming decades, it provides no specific revenue figures or dollar-valued market size. Legal advisors are identified as Ellenoff Grossman & Schole LLP and Bratschi for Axiom, and Heussen Rechtsanwaltsgesellschaft mbH, Kellerhals Carrard, Winston & Strawn LLP, and Niedermann Rechtsanwälte for Terra Quantum. No active litigation is disclosed, though standard forward-looking statements caution about potential post-announcement legal proceedings and regulatory delays.